1. Martin WR, Eades CE, Thompson JA, Huppler RE. The effects of morphine and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976, 197:517–532.
2. Iwamoto ET. Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists. J Pharmacol Exp Ther 1981,217:451–460.
3. Vaupel DB. Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog. Eur J Pharmacol 1983,92:269–274.
4. Young GA, Khazan N. Differential neuropharmacological effects of mu, kappa and sigma opioid agonists on cortical EEG power spectra in the rat. Stereospecificity and naloxone antagonism. Neuropharmacology 1984,23: 1161–1165.
5. Berzetei-Gurske IP, Toll L. The mu-opioid activity of kappa-opioid receptor agonist compounds in the guinea pig ileum. Eur J Pharmacol 1992,212:283–286.